Leigh MacMillan Archive — Page 72 of 85

Abstract translucent golden-brown organic form with looping ring-like shapes and red accents, isolated against a black background.
July 17, 2013

Probing roles of a cell death protein

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations.

By Leigh MacMillan
Row of red upholstered waiting-room chairs along a bright wall.
July 15, 2013

Defining patient retention

Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.

By Leigh MacMillan
Multiple blue-toned sagittal MRI scans of the human brain arranged together, with white technical labels overlaid.
July 12, 2013

Methods for imaging myelin loss

Certain MRI metrics can be used to assess myelin loss in multiple sclerosis, which is important for planning and monitoring therapy.

By Leigh MacMillan
(Joe Howell / Vanderbilt)
July 11, 2013

Model for MADD mitochondrial disease

A zebrafish model of a severe mitochondrial disease will be useful for developing new therapeutic approaches.

By Leigh MacMillan
June 26, 2013

Insights on glaucoma gene mutations

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

By Leigh MacMillan
False-color medical scan showing a side-view, oval-shaped cross-section with a dense multicolored region against a black background.
June 24, 2013

Predicting cancer’s response to therapy

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.

By Leigh MacMillan